The global Friedreich’s ataxia market is experiencing notable growth, fueled by advancements in genetic research, enhanced diagnostic technologies, and increased awareness of this rare ...

Artios Pharma, which looking for newer targets that, like PARP inhibitors, affect the way tumors fix themselves, said its ...

After the FDA rejected its spinocerebellar ataxia treatment, Biohaven missed out on a $150 million payment from Oberland Capital. Now the company is reshuffling its pipeline to stay alive.

The FDA has issued a CRL to Biohaven regarding the NDA for troriluzole for the treatment of adults with spinocerebellar ataxia.

Reforming the market for prescription drugs is another topic taken up by our panel of experts during the final installment of the 2025 IOPL Hometown Forum Series at Louisburg College.

Earlier this month, Biohaven Ltd. announced it received a Complete Response Letter from the FDA declining approval of its drug candidate VYGLXIA (troriluzole) for spinocerebellar ataxia, prompting the ...

GÜIRIA, Venezuela (AP) — One was a fisherman struggling to eke out a living on $100 a month. Another was a career criminal. A third was a former military cadet. And a fourth was a down-on-his-luck bus ...

Billy Bob Thornton claims there's a 'prejudice in Hollywood' against Southerners Suspect kills Florida sheriff's deputy with his own weapon during traffic stop, police say Former Ohio State ...

People who rely on Medicare for their health insurance will soon be able to get blockbuster obesity and Type 2 diabetes drugs with $50 monthly copays under two new deals the Trump administration ...

The deal with pharmaceutical companies Eli Lilly and Company and Novo Nordisk is expected to dramatically reduce costs of Ozempic and Wegovy — which the president has affectionately dubbed "The Fat ...

WASHINGTON (AP) — Defense Secretary Pete Hegseth announced yet another deadly strike on a boat accused of ferrying drugs in the eastern Pacific Ocean, coming the same day an aircraft carrier began ...